Skip to main content
. 2022 Jun 30;107(9):2037–2050. doi: 10.3324/haematol.2022.280953

Figure 1.

Figure 1.

Management of cold agglutinin disease. DAT: direct antiglobulin test; CA: cold agglutinin; CAS: cold agglutinin syndrome; computed tomography; LDH: lactate dehydrogenase; EPO: erythropoietin; BR: bendamustine and rituximab; BTKi: Bruton tyrosine kinase inhibitor.